Predictive Factors for Blood Stream Infections in Children with Cancer

REFERENCES

• Viscoli C, Castagnola E, Giacchino M, Bloodstream infections in children with cancer: a multicentre surveillance study of the Italian Association of Paediatric Haematology and Oncology. Supportive Therapy Group-Infectious Diseases Section. Eur J Cancer. 1999;35:770–774.
   PubMed Web of Science ®Google Scholar
• Paganini HR, Aguirre C, Puppa G, Febrile Neutropenia Study Group. A prospective, multicentric scoring system to predict mortality in febrile neutropenic children with cancer. Cancer. 2007;109:2572–2579.
   PubMed Web of Science ®Google Scholar
• Basu SK, Fernandez ID, Fisher SG, Length of stay and mortality associated with febrile neutropenia among children with cancer. J Clin Oncol. 2005;23:7958–7966.
   PubMed Web of Science ®Google Scholar
• Lowis SP, Goulden N, Oakhill A. Acute complications. Infection. In: Pinkerton R, Plowman PN, Pieters R, eds. Paediatric Oncology. 3rd ed. London: Hodder Arnold Publication; 2004:635–638.
   Google Scholar
• Pizzo PA. Management of fever in patients with cancer and treatment-induced neutropenia. N Engl J Med. 1993;328:1323–1332.
   PubMed Web of Science ®Google Scholar
• Biwersi C, Hepping N, Bode U, Bloodstream infections in a German paediatric oncology unit: prolongation of inpatient treatment and additional costs. Int J Hyg Environ Health. 2009;212:541–546.
   PubMedGoogle Scholar
• Sakaguchi S, Saito M, Tsuji H, Bacterial rRNA-targeted reverse transcription-PCR used to identify pathogens responsible for fever with neutropenia. J Clin Microbiol. 2010;48:1624–1628.
   PubMed Web of Science ®Google Scholar
• Beekmann SE, Diekema DJ, Chapin KC, Doern GV. Effects of rapid detection of bloodstream infections on length of hospitalization and hospital charges. J Clin Microbiol. 2003;41:3119–3125.
   PubMed Web of Science ®Google Scholar
• Dean PP, Dark P. The diagnostic future for bloodstream infections? Intensive Care Med. 2011;37:355–356.
   PubMedGoogle Scholar
• Rondinelli PI, Ribeiro Kde C, de Camargo B. A proposed score for predicting severe infection complications in children with chemotherapy-induced febrile neutropenia. J Pediatr Hematol Oncol. 2006;28:665–670.
   PubMed Web of Science ®Google Scholar
• Santolaya ME, Alvarez AM, Becker A, Prospective, multicenter evaluation of risk factors associated with invasive bacterial infection in children with cancer, neutropenia and fever. J Clin Oncol. 2001;19:3415–3421.
   PubMed Web of Science ®Google Scholar
• Ammann RA, Hirt A, Lüthy AR, Aebi C. Identification of children presenting with fever in chemotherapy-induced neutropenia at low risk for severe bacterial infection. Med Pediatr Oncol. 2003;41:436–443.
   PubMedGoogle Scholar
• Santolaya ME, Alvarez AM, Avilés CL, Prospective evaluation of a model of prediction of invasive bacterial infection risk among children with cancer, fever, and neutropenia. Clin Infect Dis. 2002;35:678–683.
   PubMed Web of Science ®Google Scholar
• Klaassen RJ, Goodman TR, Pham B, Doyle JJ. “Low-risk” prediction rule for pediatric oncology patients presenting with fever and neutropenia. J Clin Oncol. 2000;18:1012–1019.
   PubMed Web of Science ®Google Scholar
• Macher E, Dubos F, Garnier N, Predicting the risk of severe bacterial infection in children with chemotherapy-induced febrile neutropenia. Pediatr Blood Cancer. 2010;55:662–667.
   PubMed Web of Science ®Google Scholar
• Baorto EP, Aquino VM, Mullen CA, Clinical parameters associated with low bacteremia risk in 1100 pediatric oncology patients with fever and neutropenia. Cancer. 2001;92:909–913.
   PubMed Web of Science ®Google Scholar
• Asturias EJ, Corral JE, Quezada J. Evaluation of six risk factors for the development of bacteremia in children with cancer and febrile neutropenia. Curr Oncol. 2010;17:59–63.
   PubMed Web of Science ®Google Scholar
• Ammann RA, Hirt A, Lüthy AR, Aebi C. Predicting bacteremia in children with fever and chemotherapy-induced neutropenia. Pediatr Infect Dis J. 2004;23:61–67.
   PubMed Web of Science ®Google Scholar
• Spasova MI, Grudeva-Popova JG, Kostyanev SS, Risk index score for bacteremia in febrile neutropenic episodes in children with malignancies. J BUON. 2009;14:411–418.
   PubMedGoogle Scholar
• Aquino VM, Tkaezewski Y, Buchanan G. Early discharge of low-risk febrile neutropenic children and adolescents with cancer. Clin Infect Dis. 1997;25:74–78.
   PubMed Web of Science ®Google Scholar
• Aquino VM, Buchanan GR, Tkaczewsky Y, Safety of early hospital discharge of selected febrile children and adolescents with cancer with prolonged neutropenia. Med Pediatr Oncol. 1997;28:191–195.
   PubMedGoogle Scholar
• Alexander SW, Walsh TJ, Freifeld AG, Pizzo PA. Infectious complications in pediatric cancer patients. In: Pizzo PA, Poplack DG, eds. Principles and Practice of Pediatric Oncology. 4th ed. Philadelphia, PA: Lippincott Williams & Wilkins, 2002:1239–1283.
   Google Scholar
• Klastersky J, Paesmans M, Rubenstein EB, The multinational association for supportive care in cancer risk index: a multinational scoring system for identifying low-risk. J Clin Oncol. 2000;18:3038–3051.
   PubMed Web of Science ®Google Scholar
• Alexander SW, Wade KC, Hibberd PL, Parsons SK. Evaluation of risk prediction criteria for episodes of febrile neutropenia in children with cancer. J Pediatr Hematol Oncol. 2002;24:38–42.
   PubMed Web of Science ®Google Scholar
• Hann I, Viscoli C, Paesmans M, A comparison of outcome from febrile neutropenic episodes in children compared with adults: results from four EORTC studies, International Antimicrobial Therapy Cooperative Group (IATCG) of the European Or. of the European Organization for Research and Treatment of Cancer (EORTC). Br J Haematol. 1997;99:580–588.
   PubMed Web of Science ®Google Scholar
• Lai HP, Hsueh PR, Chen YC, Bacteremia in hematological and oncological children with febrile neutropenia: experience in a tertiary medical center in Taiwan. J Microbiol Immunol Infect. 2003;36:197–202.
   PubMedGoogle Scholar
• Lucas KG, Brown AE, Armstrong D, The identification of febrile, neutropenic children with neoplastic disease at low risk for bacteremia and complications of sepsis. Cancer. 1996;77:791–798.
   PubMed Web of Science ®Google Scholar
• Madsen K, Rosenman M, Hui S, Breitfeld PP. Value of electronic data for model validation and refinement: bacteremia risk in children with fever and neutropenia. J Pediatr Hematol Oncol. 2002;24:256–262.
   PubMedGoogle Scholar
• Rackoff WR, Gonin R, Robinson C, Predicting the risk of bacteremia in children with fever and neutropenia. J Clin Oncol. 1996;14:919–924.
   PubMed Web of Science ®Google Scholar
• Kelly MJ, Vivier PM, Panken TM, Schwartz CL. Bacteremia in febrile nonneutropenic pediatric oncology patients. Pediatr Blood Cancer. 2010;54:83–87.
   PubMedGoogle Scholar
• Pizzo PA, Robichaud KJ, Wesley R, Commers JR. Fever in the pediatric and young adult patient with cancer. A prospective study of 1001 episodes. Medicine (Baltimore). 1982;61:153–165.
   PubMed Web of Science ®Google Scholar
• Scheinemann K, Ethier MC, Dupuis LL, Utility of peripheral blood cultures in bacteremic pediatric cancer patients with a central line. Support Care Cancer. 2010;18:913–919.
   PubMedGoogle Scholar
• Richardson MW, Grewal SS, Visintainer PF. Emesis predicts bacteremia in immunocompromised children with central venous catheters and fever. Cancer. 2009;115:3335–3340.
   PubMedGoogle Scholar
• Allen RC, Holdsworth MT, Johnson CA, Risk determinants for catheter-associated blood stream infections in children and young adults with cancer. Pediatr Blood Cancer. 2008;51:53–58.
   PubMed Web of Science ®Google Scholar
• Hakim H, Flynn PM, Srivastava DK, Risk prediction in pediatric cancer patients with fever and neutropenia. Pediatr Infect Dis J. 2010;29:53–59.
   PubMedGoogle Scholar